NDC codes

FDA NDC Directory
Product NDC (as listed)80425-0367Labeler and product segments. Claims need a package NDC.
Product NDC at billing width80425-0367Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
80425-0367-1804250367018 POUCH in 1 BOX (80425-0367-1) / 4 PATCH in 1 POUCH / 2.7 g in 1 PATCHMarketed from Nov 27, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Trubrexa
Generic name (nonproprietary)
lidocaine and capsaicin
Active ingredients
Capsaicin — .00025 g/gLidocaine — .0475 g/g
Dosage form
Patch
Route
Transdermal
Product type
Prescription drug
Marketing category
Unapproved drug (other)
Marketing start
Listing expires
Other FDA classes
Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers
Product ID 80425-0367_1b6a417e-c708-2d58-e063-6394a90a6ba4SPL ID 1b6a417e-c708-2d58-e063-6394a90a6ba4SPL set ID 0b28733a-1ac1-5e20-e063-6394a90a41f6RxCUI 2667457UNII S07O44R1ZM, 98PI200987
Pharmacologic class
Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N480425036701 followed by a unit qualifier and the quantity

Package 80425-0367-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

1. INDICATIONS & USAGE Trubrexa TM Transdermal Patch is indicated in adults over the age of 12 years old for the treatment of acute and chronic pain in muscles and joints associated with muscle soreness, strains, sprains, arthritis, simple backache, muscle stiffness, and more.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in